Interleukin 27 (IL-27): A Novel Pleiotropic Cytokine Involved in T Cell Differentiation and T Cell Response Modulation

Pflanz S. Hibbert L. Mattson J. Rosales R. Vaisberg E. Bazan J.F. Phillips J.H. McClanahan T.K. de Waal Malefyt R. Kastelein R.A. , 2004. WSX-1 and glycoprotein 130 constitute a signal-transducing receptor for IL-27. J. Immunol. 172:2225.

Frydas S. Hatzistilianou M. Karagouni E. Madhappan B. D'Orazio N. Riccioni G. Conti F. Carratelli G. Kempuraj D. , 2003. Chemokines and parasites. Int. J. Immunopathol. Pharmacol. 16:221.

Hunter C.A. Villarino A. Artis D. Scott P. , 2004. The role of IL-27 in the development of T-cell responses during parasitic infections. Immunol. Rev. 202:106.

Cooper E.L. Hrzenjak T.M. Grdisa M. , 2004. Alternative sources of fibrinolytic, anticoagulative, antimicrobial and anticancer molecules. Int. J. Immunopathol. Pharmacol. 17:237.

Kempuraj D. Frydas S. Conti P. Kandere K. Boucher W. Letourneau R. Madhappan B. Huang S.H. Koreaki S. Christodoulou S. Theoharides T.C. , 2003. Interleukin-25: A new IL-17 family member with growth factor/inflammatory action. Int. J. Immunopathol. Pharmacol. 16:185.

Pearl J.E. Khader S.A. Solache A. Gilmartin L. Ghilardi N. Desauvage F. Cooper A.M. , 2004. IL-27 signaling compromises control of bacterial growth in mycobacteria-infected mice. J. Immunol. 173:7490.

Kempuraj D. Frydas S. Karagouni E. Hatzistilianou M. Boscolo P. Ferro F. Di Giannantonio M. Conti C.M.V. Merlitti D. Doyle R. Petrarca C. Castellani M.L. Theoharides T.C. , Cytokines and the brain. 2004. Int. J. Immunopathol. Pharmacol. 17:229.

Sessa R. Di Pietro M. Schiavoni G. Nicoletti M. Soda G. Nardoni S. Bosco D. Santino I. Cipriani P. del Piano M. , 2004. Detection of Chlamydia pneumoniae in atherosclerotic coronary arteries. Int. J. Immunopathol. Pharmacol. 17:301.

Salcedo R. Stauffer J.K. Lincoln E. Back T.C. Hixon J.A. Hahn C. Shafer-Weaver K. Malyguine A. Kastelein R. Wigginton J.M. , 2004. IL-27 mediates complete regression of orthotopic primary and metastatic murine neuroblastoma tumors: Role for CD8+ T cells. J. Immunol. 173:7170.

Goldberg R. Zohar Y. Wildbaum G. Geron Y. Maor G. Karin N. , 2004. Suppression of ongoing experimental autoimmune encephalomyelitis by neutralizing the function of the p28 subunit of IL-27. J. Immunol. 173:6465.

Parruti G. Ballone E. Tarquini P. Falasca K. D'Amico G. Agostinone A. Placido G. Graziani V. Di Giammartino D. Dalessandro M. Vecchiet J. Di Nicola M. Schioppa F. Alterio L. Consorte A. Toro G. Marani . 2003. Dual nucleoside therapy for HIV infection: Analysis of results and factors influencing viral response and long term efficacy. Int. J. Immunopathol. Pharmacol. 16:81.

Vojdani A. Pangborn J. B. Vojdani E. Cooper E.L. , 2003. Infections, toxic chemicals and dietary peptides binding to lymphocyte receptors and tissue enzymes are major instigators of autoimmunity in autism. Int. J. Immunopathol. Pharmacol. 16:189.

Kaneider N.C. Kaser A. Tilg H. Ricevuti G. Wiedermann C.J. , 2003. CD40 ligand-dependent maturation of human monocyte-derived dendritic cells by activated platelets. Int. J. Immunopathol. Pharmacol. 16:225.

Arena A. Enzo B. Enrico G. Marco B. Graziella R. , 2003. Specific immunotheraphy of allergic diseases: A three years perspective observational study. Int. J. Immunopathol. Pharmacol. 16:277.

Acharya A. Tripathi V. , 2003. Novel peptides enhance the production of nitric oxide and inducible nitric oxide synthase (iNOS) gene expression in murine macrophage. Int. J. Immunopathol. Pharmacol. 16:241.

Pannone G. Bufo P. Caiaffa M.F. Serpico R. Lo Muzio L. Rubini C. Staibano S. Petruzzi M. De Benedictis M. Tursi A. De Rosa G. Macchia L. , 2004. Cyclooxygenase-2 expression in oral squamous cell carcinoma. Int. J. Immunopathol. Pharmacol. 17:273.

Trubiani O. Guarnieri S. Orciani M. Salvolini E. Di Primio R. , 2004. Sphingolipid microdomains mediate CD38 internalization: Topography of the endocytosis. Int. J. Immunopathol. Pharmacol. 17:293.

Prosperi C. Scali C. Barba M. Bellucci A. Giovannini M.G. Pepeu G. Casamenti F. , 2004. Comparison between flurbiprofen and its nitric oxide-releasing derivatives HCT-1026 and NCX-2216 on αβ (1-42)-induced brain inflammation and neuronal damage in the rat. Int. J. Immunopathol. Pharmacol. 17:317.

Frydas S. Karagouni E. Hatzistilianou M. Kempuraj D. Comani S. Petrarca C. Iezzi T. Verna N. Conti P. Castellani M.L. , 2004. Chemokines and allergic disorders: A revised study. Int. J. Immunopathol. Pharmacol. 17:233.

Romano A. Mondino C. Viola M. Montuschi P. , 2003. Immediate allergic reactions to β-lactams: Diagnosis and therapy. Int. J. Immunopathol. Pharmacol. 16:19.

Gioia C. Agrati C. Goletti D. Vincenti D. Carrara S. Amicosante M. Casarini M. Giosue S. Puglisi G. Rossi A. Colizzi V. Pucillo L.P. Poccia F. , 2003. Different cytokine production and effector/memory dynamics of αβ⁺ or γδ T-cell subsets in the peripheral blood of patients with active pulmonary tuberculosis. Int. J. Immunopathol. Pharmacol. 16:247

Zorzetto M. Ricevuti G. Martinetti M. Gritti D. Gasparetto C. De Silvestri A. Salvaneschi L. Cuccia M. , 2004. HLA and hypocomplementemia: The disadvantage of carrying the HLA-b35 and the silent alleles of the C4 complement component. Int. J. Immunopathol. Pharmacol. 17:307.

Trubiani O. Salvolini E. Staffolani R. Di Primio R. Mazzanti L. , 2003. DMSO modifies structural and functional properties of RPMI-8402 cells by promoting programmed cell death. Int. J. Immunopathol. Pharmacol. 16:253.

Austen W.G. Jr. Kobzik L. Carroll M.C. Hechtman H.B. Moore F.D. Jr , 2003. The role of complement and natural antibody in intestinal ischemia-reperfusion injury. Int. J. Immunopathol. Pharmacol. 16:1.

Pietropaolo V. Fioriti D. Simeone P. Videtta M. Di Taranto C. Arancio A. Orsi N. Degener A.M. , 2003. Detection and sequence analysis of human polyomaviruses DNA from autoptic samples of HIV-1 positive and negative subjects. Int. J. Immunopathol. Pharmacol. 16:269.

Riccioni G. De Santis A. Cerasa V. Menna V. Di Ilio C. Schiavone C. Ballone E. D'Orazio N. , 2003. Atherosclerotic plaque formation and risk factors. Int. J. Immunopathol. Pharmacol. 16:25.

Gianotti N. Lazzarin A. , 2003. Managing failure to antiretroviral drugs in HIV-1-infected patients. Int. J. Immunopathol. Pharmacol. 16:9.

Manna R. Miele L. La Regina M. Greco A. Gasbarrini G. , 2003. Cryoglobulinaemia: A true intemistic disease? Int. J. Immunopathol. Pharmacol. 16:33.

Pannellini T. Iezzi M. Di Carlo E. Eleuterio E. Coletti A. Modesti A. Rosini S. Neri M. Musiani P. , 2004. The expression of LEC/CCL16, a powerful inflammatory chemokine, is upregulated in ulcerative colitis. Int. J. Immunopathol. Pharmacol. 17:171.

Alexandrakis M.G. Kyriakou D.S. Seretakis D. Boucher W. Letourneau R. Kempuraj D. Theoharides T.C. , 2003. Inhibitory effect of retinoic acid on proliferation, maturation and tryptase level in human leukemic mast cells (Hmc-1). Int. J. Immunopathol. Pharmacol. 16:43.

Camera E. Lisby S. Dell'Anna M.L. Santucci B. Paganelli R. Baadsgaard O. Picardo M. , 2003. Mononuclear cell antioxidant pattern and skin reactivity to irritants. Int. J. Immunopathol. Pharmacol. 16:49.

Bruno G. Tega F. Bruno A. Graf U. Corelli F. Molfetta R. Barucco M. , 2003. The role of substance P in the cerebral ischemia. Int. J. Immunopathol. Pharmacol. 16:67.

Sardella G. Accapezzato D. Di Roma A. Iacoboni C. Francavilla V. Benedetti G. Musto C. Fedele F. Bruno G. Paroli M. , 2004. Integrin β₂-chain (CD18) over-expression on CD4⁺ T cells and monocytes after ischemia/reperfusion in patients undergoing primary percutaneous revascularization. Int. J. Immunopathol. Pharmacol. 17:165.

Sodin-Semrl S. Spagnolo A. Mikus R. Barbaro B. Varga J. Fiore S. , 2004. Lipoxin A₄ and serum amyloid A elicit opposite interleukin-8 and NF-κB responses via the common ALX receptor. Int. J. Immunopathol. Pharmacol. 17:145.

Robinson D.S. O'Garra A. , 2002. Further checkpoints in Th1 development. Immunity 16:755.

Artis D. Villarino A. Silverman M. He W. Thornton EM. Mu S. Summer S. Covey T.M. Huang E. Yoshida H. Koretzky G. Goldschmidt M. Wu G.D. de Sauvage F. Miller H.R. Saris C.J. Scott P. Hunter C.A. , 2004. The IL-27 receptor (WSX-1) is an inhibitor of innate and adaptive elements of type 2 immunity. J. Immunol. 173:5626.

Redecke V. Hacker H. Datta S.K. Fermin A. Pitha P.M. Broide D.H. Raz E. , 2004. Cutting edge: Activation of Toll-like receptor 2 induces a Th2 immune response and promotes experimental asthma. J. Immunol. 172:2739.